Litigation Details for In Re: Testosterone Replacement Therapy Products Liability Litigation (N.D. Ill. 2014)

In Re: Testosterone Replacement Therapy Products Liability Litigation (N.D. Ill. 2014)

Docket		Date Filed	2014-03-14
Court	District Court, N.D. Illinois	Date Terminated	2014-03-14
Cause	28:1332 Diversity-Product Liability	Assigned To	Matthew F. Kennelly
Jury Demand	Plaintiff	Referred To
Patents	6,503,894
Link to Docket	External link to docket

Details for In Re: Testosterone Replacement Therapy Products Liability Litigation (N.D. Ill. 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
2015-11-23	1074	other	filed U.S. Patent No. 6,503,894 (“the ‘894 Patent”) with the U.S. Patent Office for pharmaceutical…AndroGel that is registered with the United States Patent and Trademark Office. 24. Defendant … b. Besins Inc. holds the U.S. patent for the pharmaceutical formulation …property right to it. Acrux DDS Pty Ltd. owns the patents for Axiron. Acrux is thus also sued in connection….” d. On January 7, 2003, the ’894 Patent was issued to Unimed and Besins as	External link to document
2015-05-22	777	other	. filed U.S. Patent No. 6,503,894 (“the ‘894 Patent”) with the U.S. Patent Office for pharmaceutical…AndroGel that is registered with the United States Patent and Trademark Office. 24. Defendant Solvay… b. Besins Inc. holds the U.S. patent for the pharmaceutical formulation …property right to it. Acrux DDS Pty Ltd. owns the patents for Axiron. Acrux is thus also sued in connection…Hypogonadism.” d. On January 7, 2003, the ’894 Patent was issued to Unimed and Besins as co-	External link to document